The clinical utility of bone marker measurements in osteoporosis.
about
Natural Products from Chinese Medicines with Potential Benefits to Bone HealthBone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women's health practiceBone turnover markers: Emerging tool in the management of osteoporosisRelationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing ParathyroidectomyBone-Protective Effects of Dried Plum in Postmenopausal Women: Efficacy and Possible Mechanisms.Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomyExpressions and clinical significance of serum bone Gla-protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosisThe biological effects of tocotrienol on bone: a review on evidence from rodent models.Bone remodeling markers and bone metastases: From cancer research to clinical implicationsRisk factors of adjacent vertebral collapse after percutaneous vertebroplasty for osteoporotic vertebral fracture in postmenopausal womenOverview of research studies on osteoporosis in menopausal women since the last decade.Decreased Bone Mineral Density at the Femoral Neck and Lumbar Spine in South Indian Patients with Type 2 Diabetes.Effect of antiresorptive and anabolic bone therapy on development of osteoarthritis in a posttraumatic rat model of OAShort-Term Isoflavone Intervention in the Treatment of Severe Vasomotor Symptoms after Surgical Menopause: A Case Report and Literature ReviewChanges in the plasma levels of several bone markers in newborn calves during the first two days of lifeAdiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury.Diagnostic performance of osteocalcin measurements in patients with endogenous Cushing's syndrome.The association between bone turnover markers and kyphosis in community-dwelling older adults.Circulating microRNAs Correlated with Bone Loss Induced by 45 Days of Bed Rest.Effect of vitamin D3-supplementation on bone markers (serum P1NP and CTX): A randomized, double blinded, placebo controlled trial among healthy immigrants living in NorwayBone markers and osteoporosis therapy.Is calcaneal quantitative ultrasound useful as a prescreen stratification tool for osteoporosis?Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study.Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials.The Effect of Taichi Practice on Attenuating Bone Mineral Density Loss: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.In Situ Sensor Advancements for Osteoporosis Prevention, Diagnosis, and Treatment.Pediatric Osteoporosis: Diagnosis and Treatment Considerations.Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.Bone turnover markers in sheep and goat: A review of the scientific literature.Circulating markers of bone turnover.Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated ModificationsReview article: effects of type 2 diabetes therapies on bone metabolism.The effects of short-term jump training on bone metabolism in females using oral contraceptives.Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency.Low Doses of Simvastatin Potentiate the Effect of Sodium Alendronate in Inhibiting Bone Resorption and Restore Microstructural and Mechanical Bone Properties in Glucocorticoid-Induced Osteoporosis.Bone Mineral Density is Lower in Patients with Severe Knee Osteoarthritis and Attrition.Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial.Dietary Patterns and Fractures Risk in the Elderly.
P2860
Q26765485-4BFEAA71-C431-46BB-9E64-09EB4FFBBCCAQ28066185-0EB935CB-E8A0-48C9-BCA1-B2B29433264AQ28074551-EC4F3BE6-A98C-43E5-9635-D082AA6362DAQ28546638-A8090D96-AA84-42F2-9B99-C395C3530613Q33749496-29118889-2F86-4283-8196-B7989431220DQ34317162-3978DC38-C84A-45D5-88BD-8447DE22407CQ35277349-B079D57F-7D27-4999-82D7-5691B9941966Q35410229-C0929FDB-D2BB-4CDE-992E-AC5916A33100Q35531006-2BCDB820-45A5-4BBA-B09E-93C115A28105Q35891879-208E24C3-45BA-4B59-9CDF-ADE1814F85DDQ36159390-711F1AA0-A92A-429F-91B5-320DFD5883ECQ36163043-F5A2FAD8-F5B4-4A6D-B627-470BEAF726E6Q36255352-246A67EE-161B-41D4-8CC1-77C147731624Q36271933-16562D35-76D7-4C00-9DA8-03487875DEE6Q36669920-980BE891-D779-42D7-ADAA-9515DF1BC038Q36885350-19F9708E-0E9C-42C9-B653-3A32FD42FB26Q37007565-A277AE07-68F4-41DC-9A76-DFA4A5286A65Q37051639-637812A9-1E03-4F08-82B8-C7FD646EAD31Q37639778-96AACE7C-FD08-4747-803C-A95B903F275EQ37720395-2DFC583B-AC23-487A-A539-32C973FE6DADQ38244170-251C01AC-E966-4278-8B8C-1FC77D73C0FEQ38337303-0E798AF0-4647-41FA-B757-42AE149FA30AQ38426359-65745A2A-BCEC-4C40-93A2-B1A4370BDB22Q38503214-5F9ACAE4-85DD-47F0-9407-CEAD8926FDCCQ38598056-788D2CED-6BAF-49F7-8849-169A57CC6B03Q38787494-ADB08A97-3727-4B64-AE33-A57BC78EDDEDQ38798360-A8C97EE0-EB8C-4F4B-887B-39BE94AB7477Q38921958-50FC1F09-6A8C-438D-8195-4A9ED62B2042Q39022309-01215067-DDD5-4DB9-9C36-F7A96898927CQ39168502-ADCBA8C7-0657-4AC4-8A43-AF28AA9D01BDQ39304775-2E959C32-C0AB-4231-BE10-7193CDA24A62Q40679886-B06E9500-6C2C-47FC-BD63-34F932EC90C4Q42363966-4B769F50-9C08-4EF5-BDE2-FA88A64EC40CQ46026235-E158EC7F-83CE-48C8-9816-787A962853B6Q47116443-01E5BF23-1A16-4FD9-9EFB-8DC74DAD8012Q48029073-1F6C22AA-39DB-40AF-9D96-4DB67DFB9EB1Q48055309-D8D6284D-CEB4-4A6C-88F6-6EF46E293BE3Q48235237-14B09C28-513D-4085-A562-0820360FE9EAQ48332923-56AA4A5F-2C5D-4A4A-8E93-374D55681D3EQ49631462-0F873BC8-7DD4-4307-9666-FE6084CFD085
P2860
The clinical utility of bone marker measurements in osteoporosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical utility of bone marker measurements in osteoporosis.
@en
The clinical utility of bone marker measurements in osteoporosis.
@nl
type
label
The clinical utility of bone marker measurements in osteoporosis.
@en
The clinical utility of bone marker measurements in osteoporosis.
@nl
prefLabel
The clinical utility of bone marker measurements in osteoporosis.
@en
The clinical utility of bone marker measurements in osteoporosis.
@nl
P2093
P2860
P921
P356
P1476
The clinical utility of bone marker measurements in osteoporosis.
@en
P2093
Gillian Wheater
Harish K Datta
Jacob M van Laar
Mohsen Elshahaly
Stephen P Tuck
P2860
P2888
P356
10.1186/1479-5876-11-201
P5008
P577
2013-08-29T00:00:00Z
P5875
P6179
1001368448